Andrew Cohen is an associate in the firm’s Litigation department, concentrating on biotech and pharmaceutical patent litigation. He holds a Ph.D. in Organic Chemistry from Johns Hopkins University and an undergraduate degree in Chemistry from Princeton University. He has represented biotech and pharmaceutical companies in patent litigation on a variety of subject matters ranging from small molecules to biologics to medical devices. He has experience litigating cases brought under the Hatch-Waxman act, and is representing an innovator pharmaceutical company in one of the first cases under the U.S. biosimilars legislation (the BPCIA). Mr. Cohen, a registered patent attorney, has also represented a client in an inter partes review (IPR), a patent office trial proceeding. He has a wide range of subject matter experience in the biotech and pharmaceutical arts, including small molecule pharmaceuticals, humanized antibodies, recombinant DNA technology, and protein-polymer conjugates. He is also an inventor on several issued patents relating to clinical-stage small molecules for the treatment of heart failure.
From 2012 to 2013, Mr. Cohen served as a law clerk to the Hon. Cathy Seibel of the United States District Court for the Southern District of New York. Prior to clerking, Mr. Cohen also spent three years as a patent agent at an international law firm, where he worked on motion practice, patent prosecution, due diligence, opinion drafting and patent prosecution. Before that, he was a scientific advisor for three years at a boutique intellectual property law firm, where he worked on several Hatch-Waxman litigations, as well as due diligence, opinion drafting and patent prosecution. Mr. Cohen was recognized in 2017 as a Rising Star in the New York-Metro edition of Super Lawyers.
Mr. Cohen is a frequent contributor to the firm’s BiologicsBlog.com, which tracks and analyzes developments in intellectual property law related to biotechnology and biologic medical products as well as regulatory and legislative changes.
- U.S. Supreme Court
- U.S. Patent and Trademark Office
- U.S. Court of Appeals, Federal Circuit
- U.S. District Court, Southern District of New York
- U.S. Court of International Trade
- New York
MEMBERSHIPS: American Chemical Society; New York City Bar Association (Member of the Patents Committee); New York Intellectual Property Law Association (Member of the Amicus Briefs Committee); Federal Bar Council.